Hospital Care Deals and Alliances of 2013

  • August 2014
  • -
  • Currentpartnering
  • -
  • 200 pages

The Hospital Care Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2013.

Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide.

The initial chapters of this report provide an orientation of 2013’s dealmaking and business activities.

Chapter 1 provides an overview of the trends in dealmaking during 2013 covering trends by deal type, stage of development, technology type and therapeutic indication.

Chapter 2 provides a review of the leading deals during 2013. Deals are listed by headline value, signed by bigpharma and bigbiotech, and most active bigpharma. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 3 provides a comprehensive listing of the top 50 bigpharma companies with a brief summary followed by a comprehensive listing of 2013 deals, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Chapter 4 provides a comprehensive directory of all partnering deals announced during 2013.

The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), therapy area and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report series also includes numerous tables and figures that illustrate the trends and activities in bigpharma partnering and dealmaking during 2013.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products during 2013.

Table Of Contents

Executive Summary

Chapter 1 - Trends in dealmaking during 2013

1.1. Bigpharma dealmaking activity
1.2. Partnering by deal type
1.3. Partnering by industry sector
1.4. Partnering by stage of development
1.5. Partnering by technology type
1.6. Partnering by therapy area

Chapter 2 - Leading deals during 2013

2.1. Introduction
2.2. Top deals by value during 2013

Chapter 3 - Bigpharma deals during 2013

3.1. Introduction
3.2. How to use bigpharma partnering deals
3.3. Bigpharma partnering company profiles for 2013
Abbott
Actavis
Actelion
Allergan
Amgen
Aspen Pharmacare
Astellas
AstraZeneca
Baxter International
Bayer
Biogen Idec
Boehringer Ingelheim
Bristol-Myers Squibb
Celgene
CSL
Daiichi Sankyo
Dainippon Sumitomo
Eisai
Eli Lilly
Endo Pharmaceuticals
Forest Laboratories
Galderma
Gilead Sciences
GlaxoSmithKline
Grifols
Hospira
Johnson and Johnson
Kyowa Hakko Kirin
Lundbeck
Menarini
Merck and Co
Merck KGaA
Mitsubishi Tanabe
Novartis
Novo Nordisk
Otsuka
Pfizer
Purdue
Roche
Sanofi
Servier
Shionogi
Shire
Takeda
Teva
Valeant
Warner Chilcott
Watson

Chapter 4 - Partnering deals directory 2013

4.1. Introduction
4.2. Company A-Z
4.3. By deal type
4.4. By stage of development
4.5. By technology type
4.6. By therapy area

About Wildwood Ventures

Current Partnering
Current Agreements
Current Reports
Recent titles from CurrentPartnering
Order Form - Reports


Table of figures

Figure 1: Bigpharma - top 50 - January to December 2013
Figure 2: Bigpharma deal frequency - 2013
Figure 3: Partnering by deal type during 2013
Figure 4: Partnering by industry sector during 2013
Figure 5: Partnering by stage of development during 2013
Figure 6: Partnering by technology type during 2013
Figure 7: Partnering by therapy area during 2013
Figure 8: Top deals by value during 2013

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Hospital Care Partnering Terms and Agreements

Hospital Care Partnering Terms and Agreements

  • $ 2 995
  • Industry report
  • August 2014
  • by Currentpartnering

The Hospital Care artnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter hospital care partnering deals. The majority of deals are discovery, ...

Asia Medical Tourism Analysis & Forecast

Asia Medical Tourism Analysis & Forecast

  • $ 2 800
  • Industry report
  • November 2014
  • by Renub Research

Medical tourism is now a popular term globally and it has whole new different meaning to different countries. For Americans it means saving on medical expenses. Here the lower income group or middle income ...

Healthcare Buildings Construction in Hong Kong to 2018: Market Databook

Healthcare Buildings Construction in Hong Kong to 2018: Market Databook

  • $ 500
  • Industry report
  • October 2014
  • by Timetric

Synopsis Timetric's 'Healthcare Buildings Construction in Hong Kong to 2018: Market Databook' contains detailed historic and forecast market value data for the healthcare buildings construction industry, ...


1 Companies

Company Profiles

Walgreen Co.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.